nanotech-investing Universal Ibogaine provides Bi-weekly Default Status Report on 2025 year-end filings and update on Restructuring process
nanotech-investing Universal Ibogaine Provides Bi-weekly Default Status Report on 2025 Year-end Filings and Update on Restructuring Process
nanotech-investing Universal Ibogaine advises further on application for Management Cease Trade Order